Robert Brooke Chief Executive Officer
|
|
- Janel Johnson
- 6 years ago
- Views:
Transcription
1 Robert Brooke Chief Executive Officer
2 2 Safe Harbor Statement Our commentary and responses to your questions may contain forward-looking statements, including comments concerning product development programs, evaluation of potential opportunities, the level of corporate expenditures, the assessment of our technology by potential corporate partners, capital market conditions, timing of events, cash consumption and other subjects. Information concerning factors that could cause actual results to differ materially from those set forth in our regulatory filings from time to time.
3 3 We are an agricultural-biotechnology company building technologies and products that enable sustainable health Population growth and surging consumption is a ticking time bomb We need mass market solutions.
4 4 Sugar: Consumption at a Crossroads Credit Suisse Report, September 2013 Key conclusion: The most likely outcome over the next 5-10 years will be a significant reduction in sugar consumption and a marked increase in the role played by high-intensity natural sweeteners in foods and beverages.
5 5 Healthy product introductions at big companies are usually risky, but stevia is a no-brainer. Natural Sweeteners (sugar, honey,) Stevia natural zero calories Artificial Sweeteners (aspartame, saccharin, etc.) The holy grail of sweeteners is still in its infancy, but delivering on numerous fronts, and has strategic and technical competitive advantages that indicate it will be a winner long-term.
6 6 Stevia First s agri-bio technologies aim to define the future of stevia use and the stevia industry Stevia Fermentation: No leaf required through microbial fermentation Reliable, scaleable, and on-demand production of stevia that is tailored to consumer taste preferences Modern Ag and Hybrid-Fermentation: Leaf required in small quantities Expertise in domestic organic leaf production and extraction, providing capability for traditional or hybrid-fermentation production that eliminate necessity of overseas stevia plantations
7 7 Biosynthesis of Steviol Glycosides using the native stevia enzymes to produce Nature-Identical TM Stevia Source: Phytochemistry, Brandle, et.al., 2007
8 Intellectual Property related to Steviol Production using Fermentation Compositions and methods for producing steviol and steviol glycosides Patents and patent applications related to production of steviol and steviol glycosides through fermentation Steviol The Golden Gate Stevia 1.0 (Stevioside) Lower -cost inputs Stevia 2.0 (Reb A) Stevia 3.0 (Reb D?)
9 9 Pipeline Stevia and Next-Generation Stevia Sweeteners Stevia RA95 Stevia extract containing more than 95% Reb A. Process Discovery Process Development Process Scaleup Regulatory Approval Product Launch Stevia SGN95 ( Beyond Reb A ) Stevia extract containing more than 95% total Steviol Glycosides in Novel formulations. Process Discovery Process Development Process Scaleup Regulatory Approval Product Launch Fermentation-based production, modern organic leaf production, and hybrid production methods can be utilized based on consumer preferences
10 10 Strategic Product Development Through launching branded consumer products now, we re raising awareness for... our mission, and healthy product innovations that can influence the mass market. SF Natural TM - enjoy sweetness in its most natural form Sucrolette TM - we can quit sugar together in 5 weeks Dr. Mike Murray, ND -leading authority on natural approaches to health and wellness - Editor, The Encyclopedia of Natural Medicine Product Development Personalities Alexandra Jamieson -Nutrition counselor, health writer, and chef - Super Size Me documentary - Featured on Oprah, CNN, MSNBC
11 11 Stevia Production Platform On-demand production of stevia extracts to meet a wide variety of consumer demands and application needs Path to Value Creation Process Discovery Process Development Proof-ofconcept data Intellectual property Process Scaleup Proof-ofrelevance data Technology partnerships Key Drivers Commercial Validation Technology partnerships Commercial launch partnerships Commercial Launch Regulatory Approval Marketing partnerships Product Revenues
12 12 Leadership Avtar Dhillon, MD, Chairman & Cofounder Chairman, Inovio and Oncosec Venture capitalist Family medicine physician Anthony Maida, PhD, MBA, Director COO, Northwest Bio MBA, MA in Toxicology, PhD in Immunology, Family farm management experience Robert Brooke, CEO & Co-founder Ex-hedge fund analyst for over 50 direct healthcare investments Biotech entrepreneur, M.S. in Biomedical Engineering Jeremiah Mann, PhD, Sr. Agronomist, VP of Ops Ex-USDA and Natural Resource Conservation Service PhD in Horticulture and Agronomy, Univ of California Davis Richard McKilligan, JD, MBA, Controller Ex-Morgan, Lewis, & Bockius LLP, State Bars in CA and NY, CPA (inactive) JD from Cornell, MBA from Univ of Chicago, BS in Accounting from Univ of Illinois
13 Multidisciplinary Capabilities 13
14 14 Trading Highlights (Ticker: STVF) ~$30M market cap $0.49 share price Trading data as of Feb. 24, 2014
15 15 Financial Highlights a development-stage agricultural biotechnology firm Average volume (3m): 159,779 shares Recent financings (June & Dec. 2013): >$2.5M from stock and warrants Shareholder base: 8,351 shareholders Shares outstanding: 66,432,523 shares Auditors: Weinberg & Co. Transfer Agent: Island Stock Transfer Securities Counsel: Morrison & Foerster Stevia First Ticker: STVF Stock listing: OTCQB Stock price: $0.49 per share Market cap: ~$30 million Trading data as of Feb. 24, 2014
16 Industry Activity & Milestones INTRINSIC Entry into exclusive and worldwide license for steviol-related patents Stevia First s "Beyond Reb A" R&D Program disclosed publicly Pilot-Scale Testing of Domestic Stevia Extraction Production of Enhanced Steviol Glycosides Through Fermentation Stevia Tasting Event including Stevia using Fermentation Consumer Product Releases Aug 12 Mar 13 May 13 July 13 Dec 13 EXTRINSIC 16 Coca-Cola reformulates Sprite in UK with stevia; launches an anti-obesity ad campaign Purecircle (a leading supplier) announces Reb D is Stevia 3.0 Cargill invests in and partners with Evolva, a European company, for fermentationderived steviol glycosides Coca-Cola and Purecircle seek GRAS status and development of next-gen stevia Reb X Coca-Cola launches Coca-Cola Life using stevia and plant bottle with green labeling Data Release Process Scale-up for RA95 Data Release Process Discovery for SGN95, next-gen stevia Regulatory Update GRAS Approval Process for RA95 1H 14 Q3 14 Business Development (ongoing) Technology partnerships Commercial partnerships New licensing opportunities
17 Investment Highlights Fermentation-based stevia production is a breakthrough technology Intellectual property related to steviol glycoside production using fermentation Discussions for technology and commercial partnerships are ongoing Management and board contain leaders in biotechnology R&D with 20+ years of related public markets experience
Safe Harbor Statement
2 Safe Harbor Statement This presentation and our commentary and responses to your questions may contain forward-looking statements, including comments concerning drug development programs, evaluation
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationCorporate Presentation June OTCQB: VBIO
Corporate Presentation June 2018 @vitalitybio www.vitality.bio OTCQB: VBIO 2 Safe Harbor Statement This presentation and our commentary and responses to your questions may contain forward-looking statements,
More informationFood Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS
Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s future
More informationCorporate Presentation July
Corporate Presentation July 2016 @vitalitybio www.vitality.bio 2 Cannabinoid Prodrugs Unlocking the power of cannabinoids to treat serious neurological and inflammatory disorders 3 Leadership entrepreneurial
More informationInvestor Presentation June 2012 NASDAQ: CEMI
Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act
More informationSPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS
SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator
More informationE N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE
I N V E S T O R P R E S E N TAT I O N Q 4 2 0 1 6 TM HEALTH THERAPEUTICS E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE T S X. V: E M H DISCLAIMER THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE
More informationCorporate Presentation June OTCQB: VBIO
Corporate Presentation June 2018 @vitalitybio www.vitality.bio OTCQB: VBIO 2 Safe Harbor Statement This presentation and our commentary and responses to your questions may contain forward-looking statements,
More informationNEXT-GENERATION STEVIA: A NEW WAVE OF EXTRACTS
NEXT-GENERATION STEVIA: A NEW WAVE OF EXTRACTS April 2018 EXPERT INSIGHTS 02 Next-Generation Stevia: A New Wave of Extracts Natural sweeteners, including stevia, have been trending amid the clean label
More informationInnovation Spotlight:
Innovation Spotlight: Sugar reduction in dairy a natural fit for stevia?.. PureCircle April 2017 Agenda Reducing sugar without compromising taste Presenting consumer perception and positioning sugar reduction
More informationADVANCES IN THE SCIENCE OF THE STEVIA LEAF: A PATH TO THE BEST TASTE AND SENSORY EXPERIENCE
ADVANCES IN THE SCIENCE OF THE STEVIA LEAF: A PATH TO THE BEST TASTE AND SENSORY EXPERIENCE 1 LETS PUT THINGS INTO PERSPECTIVE CONSUMERS ARE LOOKING FOR NATUTRAL ALTERNATIVES TO REPLACE SUGAR What? Seeking
More informationCOMPANY PRESENTATION JULY Bob Bechard Executive Vice-President Corporate Development & Licensing
COMPANY PRESENTATION JULY 2018 Bob Bechard Executive Vice-President Corporate Development & Licensing Forward Looking Statements Some statements in this release may contain forward-looking information.
More informationTechnological Experiences and Advances in the Beverage Sector
Technological Experiences and Advances in the Beverage Sector Marge Leahy, PhD Director, Health and Wellness Institute of Medicine Food Forum Workshop Leveraging Food Technology for Obesity Prevention
More informationDSM Capital Markets Day 2018
DSM Capital Markets Day 2018 Human Nutrition & Health Jeremy Xu President Human Nutrition & Health ROYAL DSM CAPITAL MARKETS DAY LONDON (UK) 20 JUNE 2018 Safe harbor statement This presentation may contain
More informationMedia Kit. September 2017
Media Kit September 2017 About Pear Pear Therapeutics is the leader in FDA-cleared Prescription Digital Therapeutics. The company s approach is to integrate clinically-validated software applications with
More informationThe Stevia Plant. Zero in on Stevia Sweegen, Inc. All rights reserved.
Zero in on Stevia Zero in on Stevia 2 In 2015, when the World Health Organization (WHO) issued guidelines with recommendations on daily sugar intake 1, they would start a change in how the world viewed
More informationFEMA Mission Statement and Critical Objectives
FEMA 2014-2015 Mission Statement and Critical Objectives Mission Statement: The Flavor and Extract Manufacturers Association furthers the business interests of its members through a sound scientific program
More informationCBI Product Factsheet:
CBI Product Factsheet: Stevia in Europe CBI Market Intelligence Product Factsheet Cloves in Germany 1 Introduction Stevia is a new product in Europe. Food and beverage manufacturers are rapidly developing
More informationTSX Venture: RVV OTCQB: RVVTF
TSX Venture: RVV OTCQB: RVVTF The image part with relationship ID rid3 was not found in the file. 2017 Annual General and Special Meeting of Shareholders December 19, 2017 Revive Therapeutics Ltd. Office:
More informationHILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
More informationCorporate Overview. February 2018 NASDAQ: CYTR
Corporate Overview February 2018 NASDAQ: CYTR CytRx Safe Harbor Statement THIS PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS THAT INVOLVE CERTAIN RISKS AND UNCERTAINTIES. ACTUAL RESULTS COULD DIFFER
More informationA vertically integrated global leader in the manufacturing of all natural stevia products and traditional Chinese medicines
A vertically integrated global leader in the manufacturing of all natural stevia products and traditional Chinese medicines September 2010 www.sunwininternational.com www.onlysweet.com Legal Statemente
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We
More informationSweeteners Overview. Nutritionists in Industry /SENSE meeting 24 April 2012
Sweeteners Overview Nutritionists in Industry /SENSE meeting 24 April 2012 Helen Munday Director Scientific and Regulatory Affairs, Coca-Cola Great Britain and Ireland 1 What needs to be considered? Consumers
More informationDynavax Corporate Presentation
Dynavax Corporate Presentation Forward-Looking Statements This presentation contains forward-looking statements, including statements regarding our HEPLISAV-B TM regulatory submissions, product profile,
More informationLEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017
LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationInvestor Presentation
Investor Presentation Spring 2019 OTCQX:MDCL www.medicinemantechnologies.com SAFE HARBOR STATEMENT: This presentation may contain forward looking statements which are based on current expectations, forecasts,
More informationFiscal 2019 Annual Meeting of Shareholders December 18, Presentation by Lori Woods, Chief Executive Officer
Fiscal 2019 Annual Meeting of Shareholders December 18, 2018 Presentation by Lori Woods, Chief Executive Officer Safe Harbor Statement Statements in this presentation about IsoRay's future expectations,
More informationNASDAQ: CYTR FIGHTING CANCER WITH CUTTING EDGE SCIENCE. Corporate Overview. July 2018
NASDAQ: CYTR Corporate Overview July 2018 CytRx Safe Harbor Statement THIS PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS THAT INVOLVE CERTAIN RISKS AND UNCERTAINTIES. ACTUAL RESULTS COULD DIFFER MATERIALLY
More informationProprietary Pipeline
Revenue Generating Commercial portfolio with highquality, differentiated products in the Canadian market Proprietary Pipeline Reformulation development pipeline for drugs with a need for improved compliance
More informationCOMPANY PRESENTATION. Bernard Fortier, CEO
COMPANY PRESENTATION Bernard Fortier, CEO Forward Looking Statements Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address
More informationInvestor Presentation
Investor Presentation January 2012 Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933,
More informationARTIFICIAL SWEETENERS: A MARKET WATCH
ARTIFICIAL SWEETENERS: A MARKET WATCH BARPETE P. K. 1 *, SINGH S. 2 1, Malhotra College of Pharmacy, Bhopal, M.P-India 2, Dabur Pharma, Delhi-India ABSTRACT Artificial sweeteners are so much sweeter than
More informationMazen Animal Health. Jennifer Filbey, Ph.D. CEO March 2017
Mazen Animal Health Jennifer Filbey, Ph.D. CEO March 2017 Revolutionary Way to Prevent Disease and Save the Producer Money 2 The Strategic Opportunity NOVEL VACCINE production platform in maize enables
More informationWelcome to Galenicum! APRIL, 2013
Welcome to Galenicum! APRIL, 2013 Our corporate image comes from the sunrise. Night represents disease, daylight means health and the sunrise stands for overcoming GALENICUM CORPORATE PRESENTATION 3 Who
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationFor personal use only
ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan
More informationFor personal use only
Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development
More informationMaster of Science in Management: Fall 2018 and Spring 2019
Master of Science in Management: Fall 2018 and Spring 2019 2 - Required Professional Development & Career Workshops MGMT 7770 Prof. Development Workshop 1/Career Workshops (Fall) Wed. 9am, 12pm & 3pm MGMT
More informationSPECIALTY MEDICAL CANNABIS COMPANY
SPECIALTY MEDICAL CANNABIS COMPANY TSX Venture: RVV OTCQB: RVVTF Corporate Presentation - August 2018 ReviveThera.com Revive Therapeutics Ltd. Office: 905-605-5535 E-mail: info@revivethera.com Forward
More informationGlobal Stevia Market: Size, Trends & Forecasts ( ) July 2017
Global Stevia Market: Size, Trends & Forecasts (2017-2021) July 2017 Global Stevia Market Scope of the Report The report entitled Global Stevia Market: Size, Trends & Forecasts (2017-2021), provides analysis
More informationPierre Legault CEO June 2, 2014
April 2012 Pierre Legault CEO June 2, 2014 Forward Looking Statements This presentation includes statements that are, or may be deemed, forward-looking statements. In some cases, these forward-looking
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More information34 th Annual J.P. Morgan Healthcare Conference
JANUARY 2016 34 th Annual J.P. Morgan Healthcare Conference [ 1 ] Forward Looking Statements SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS In addition to historical information, this presentation contains
More informationDIRECT SPINAL THERAPEUTICS INC.
DIRECT SPINAL THERAPEUTICS INC. Novel Spinal Cord Modulation Platform Overview Presentation May 2014 Direct Spinal Therapeutics Inc. (DSTI) Proprietary Neuromodulation product/platform originated at Univ.
More informationAvenue Therapeutics, Inc. August 2016
Avenue Therapeutics, Inc. August 2016 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the safe
More informationMedicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, Kamau Chionesu
Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, 2017 Kamau Chionesu kamau.chionesu02@uwimona.edu.jm Questions 1. What are the likely key requirements for successful participation
More informationMaster of Business Administration: Fall 2017/Spring 2018/Fall Semesters (45 Credits)
Master of Business Administration: Fall 2017/Spring 2018/Fall 2018-3 Semesters (45 Credits) 4 Required non-credit courses: MGMT 6010 Heroes, Leaders & Innovators (Fall) TBA MGMT 7230 Professional Development
More informationLeading Cannabinoid Patient Care in Canada. Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF
Leading Cannabinoid Patient Care in Canada Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF Forward Looking Statements Except for historical information, this presentation contains forward-looking
More informationN A S D A Q : E V F M
N A S D A Q : E V F M Jefferies Global Healthcare Conference June 7, 2018 Disclaimer This presentation contains forward looking statements within the meaning of The Private Securities Litigation Reform
More information36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018
36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section
More informationMaster of Science in Management: Fall 2017 and Spring 2018
Master of Science in Management: Fall 2017 and Spring 2018 2 - Required Professional Development & Career Workshops MGMT 7770 Prof. Development Workshop 1/Career Workshops (Fall) Wed. 9am, 12pm & 3pm MGMT
More informationInvestor presentation. Bioshares Biotech Summit July 2017
Investor presentation Bioshares Biotech Summit 2017 22 July 2017 1 Disclaimer Some of the information in this presentation may refer to Dimerix Limited ( Dimerix or the Company ) based on information available
More informationOWC PHARMACEUTICAL RESEARCH OTCQB:OWCP
OWC PHARMACEUTICAL RESEARCH OTCQB:OWCP Disclaimer This document details business information of OWC Pharmaceuticals Research Corp and/or our wholly-owned Israeli subsidiary, One World Cannabis Ltd. (collectively,
More informationPresentation to 2019 JP Morgan Healthcare Conference
For immediate release 10 January 2019 Presentation to 2019 JP Morgan Healthcare Conference Please find attached CSL Limited s presentation at the 2019 JP Morgan Healthcare Conference. For further information,
More informationAvenue Therapeutics, Inc. September 2016
Avenue Therapeutics, Inc. September 2016 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the
More informationGLG Pharma, LLC. A Specialty Pharmaceutical Company developing the next generation of targeted drugs
GLG Pharma, LLC A Specialty Pharmaceutical Company developing the next generation of targeted drugs Privately Held Company Summary Experienced Management Team Development stage full spectrum Marketed Products:
More informationRespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit
RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit December 11 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston,
More informationFor personal use only. A new company with: a new technology platform for cancer drug development a new management team a new Board
A new company with: a new technology platform for cancer drug development a new management team a new Board Disclaimer This presentation is confidential and is not an offer or a recommendation or intended
More informationAnnual General Meeting 25 October Cogstate Ltd. All rights reserved.
Annual General Meeting 25 October 2017 2017 Cogstate Ltd. All rights reserved. Board of Directors Audit, Risk & Compliance Committee Remuneration & Nomination Committee Martyn Myer Non-Exec Chairman Yes
More informationAvenue Therapeutics, Inc. May 2017
Avenue Therapeutics, Inc. May 2017 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the safe
More informationWednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address
Advanced Molecular Diagnostic Systems The Walter and Eliza Hall Biotechnology Centre, 4 Research Avenue, La Trobe R&D Park, Bundoora, Victoria 3083 T: +61 (0)3 9345 2127 F: +61 (0)3 9345 2242 Wednesday
More informationMarketing Health and Nutrition: Does it Work?
Marketing Health and Nutrition: Does it Work? Julie G. Adams Almond Board of California 14 June 2011 1 Case Study in less than 15 minutes! Why demand creation is a must, not an option, for almonds Capitalizing
More informationInvestor Presentation September Cogstate Ltd. All rights reserved.
Investor Presentation September 2017 2017 Cogstate Ltd. All rights reserved. We believe that brain health is profoundly important to quality of life and should be easier to measure. That s why we so passionately
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationCAELUM BIOSCIENCES. Corporate Overview May, 2017
CAELUM BIOSCIENCES Corporate Overview May, 2017 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning
More information22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations
Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $2.21 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com
More informationAviragen Therapeutics, Inc. and Vaxart Inc. Joint Conference Call UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES
Aviragen Therapeutics, Inc. and Vaxart Inc. Joint Conference Call UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES October 30, 2017 Safe Harbor This presentation contains forward-looking statements about
More informationCorporate Presentation. October 2017
AEPP Breakthrough technology for women s cancers Corporate Presentation October 2017 Oncolix 2017 1 Safe Harbor Certain of the statements and the projections set forth in this presentation constitute forward-looking
More informationAXIM Biotechnologies Reports Year End 2017 Results
March 19, 2018 AXIM Biotechnologies Reports Year End 2017 Results NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research
More informationCorporate Presentation September 2017
Enhancing Life Through Nature TSX: CZO Corporate Presentation September 2017 www.ceapro.com 2 Forward Looking Statements This presentation contains forward-looking statements. Various factors could cause
More informationwww. isotopeworld.com Advanced Medical Isotope Corporation
www. isotopeworld.com Advanced Medical Isotope Corporation www. isotopeworld.com James C. Katzaroff Founder, CEO, Chairman December 5, 2016 Safe Harbor Statement This Overview contains forward-looking
More informationMaster of Business Administration: Fall 2018/Spring 2019/Fall Semesters (45 Credits)
Master of Business Administration: Fall 2018/Spring 2019/Fall 2019-3 Semesters (45 Credits) 3 Required non-credit courses: MGMT 7230 Professional Development Workshop I (Fall) - Wednesday 2-3:50pm MGMT
More informationN a s d a q : I N S Y
N a s d a q : I N S Y 0 Safe Harbor Statement This presentation contains both historical information and forward-looking statements. Forward-looking statements are based on management's current expectations
More informationSPECIALTY MEDICAL CANNABIS COMPANY
SPECIALTY MEDICAL CANNABIS COMPANY TSX Venture: RVV OTCQB: RVVTF Corporate Presentation - August 2018 ReviveThera.com Revive Therapeutics Ltd. Office: 905-605-5535 E-mail: info@revivethera.com Forward
More informationDuPont Nutrition & Health Craig Binetti, President
Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this
More informationOWC PHARMACEUTICALS RESEARCH OTCQB:OWCP
OWC PHARMACEUTICALS RESEARCH OTCQB:OWCP Disclaimer This document details business information of OWC Pharmaceuticals Research Corp and/or our wholly-owned Israeli subsidiary, One World Cannabis Ltd. (collectively,
More informationAnnual General Meeting
Annual General Meeting November 2017 ASX: MEB OTCQB: MDBIF Medibio Limited 2016 2 DISCLAIMER FORWARD LOOKING STATEMENTS Accordingly, these slides and the information they contain should be read in conjunction
More informationInvestor Presentation May 2, 2017
CSE: TBP OTC: GRPOF Investor Presentation May 2, 2017 Forward Looking Statements This presentation contains certain forward-looking statements that may involve a number of risks and uncertainties. Actual
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationDeveloping Xanamem for Alzheimer s Dementia
Developing Xanamem for Alzheimer s Dementia Dr. Bill Ketelbey CEO, Actinogen Medical Investor Presentation March 2015 Forward Statements This presentation has been prepared by Actinogen Limited. ( Actinogen
More informationUpdate FDA/Center for Food Safety and Applied Nutrition
Update FDA/Center for Food Safety and Applied Nutrition Comments by Susan Mayne, Ph.D. Director Center for Food Safety and Applied Nutrition FDLI Annual Conference May 3, 2018 Food Safety, Nutrition and
More informationLetter to Shareholders
Letter to Shareholders February 2019 Dear Fellow Shareholders: As Co-Founder and Chief Executive Officer of Medicine Man Technologies, Inc. (OTCQX: MDCL), I want to thank you for being a shareholder in
More informationFuture Leaders in the Biotech Industry. Lee Bendekgey, SVP, CFO & General Counsel April 7, 2005
Future Leaders in the Biotech Industry Lee Bendekgey, SVP, CFO & General Counsel April 7, 2005 Safe Harbor This presentation contains "forward-looking statements" regarding potential use of Nuvelo clinical
More informationEat Your Peas And Read Your Dietary Guidelines
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Eat Your Peas And Read Your Dietary Guidelines Law360,
More informationBioDiem to present at Hong Kong biotech investment forum
ASX Announcement BIODIEM LTD ABN 20 096 845 993 Suite 3, Level 11, 470 Collins Street, Melbourne, Victoria, 3000 Australia Phone: +613 9613 4100 Web: www.biodiem.com BioDiem to present at Hong Kong biotech
More informationKey figures (consolidated)
Nestlé Group 2013 Key figures (consolidated) In millions of CHF (except for data per share) 2013 Results Sales 92158 Trading operating profit 14047 as % of sales 15.2% Profit for the year attributable
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationImarc
Imarc www.imarcgroup.com Global Sorbitol (Glucitol) Market Report & Forecast: Market Size, Share, Growth, Production Capacity, Price, Applications, Feedstocks, Manufacturers and Forecast: 2013-2017 March
More informationChronic illness is a growing market for Novo Nordisk
Chronic illness is a growing market for Novo Nordisk Aslam Dalvi - Associate Portfolio Manager Denmark-based global healthcare company Novo Nordisk traces its origins to the first pioneers in insulin production
More informationPositioned for Growth
Positioned for Growth Annual Shareholders Meeting July 21, 2016 Paris Panayiotopoulos President and Chief Executive Officer David Sachs Non small cell lung cancer ARIAD clinical trial patient This presentation
More informationCochlear Limited 2017 Annual General Meeting Chairman s Address
Cochlear Limited 2017 Annual General Meeting Chairman s Address 17 October 2017 Rick Holliday-Smith Chairman Ladies and gentlemen Financial results Cochlear reported a record net profit of $224 million,
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationof note Sensory science addresses sugar reduction challenges
of note Sensory science addresses sugar reduction challenges Reduction and replacement of sugar is a complex matter for food and beverage manufacturers. Sugar substitutes, sweeteners and sweetness enhancers
More informationRULES OF CONDUCT OF INSIDERS RESPECTING
T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )
More informationFor personal use only
Cancer killing viruses Oncolytic Virotherapeutics Bryan Dulhunty Managing Director Bell Potter Life Sciences Conference Building a Global Profile May 2102 bryan.dulhunty@viralytics.com www.viralytics.com
More informationSumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical
For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo
More informationNew Generation of T-cell Therapeutics
New Generation of T-cell Therapeutics Corporate Overview January 2017 NASDAQ: TPIV 1 Safe Harbor Statement Certain statements contained herein are forward-looking statements within the meaning of the safe
More information